OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Urology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
CDH12-expressing cell population predicts patient response to therapy	164
Krause corpuscles act as genital vibration detectors	152
Exploratory results from the CheckMate 214 trial	124
Immune infiltration associated with outcomes	97
Semen quality recovery following COVID-19	84
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	73
Texture analysis for patient selection	66
Single-cell and spatial sequencing of kidney cancer	62
Sexual recovery interventions following prostate cancer treatment	59
Human-relevant urothelial model provides insight into infection strategies and host response	59
RAL-P in infants: expert tips for success	58
Time for women-centred gynaecology	58
PARP inhibitors plus enzalutamide to treat mCRPC	56
Urine microbiota differ in bladder cancer	56
Considering urology in a planetary context	54
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	52
Advancing the state of the art in congenital obstructive uropathy	52
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery	51
Preclinical models of bladder cancer: BBN and beyond	48
High-dose chemotherapy for relapsed testicular germ cell tumours	46
A clinical guide to rare male sexual disorders	45
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	45
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity	45
FOXA2–KIT-driven lineage plasticity in NEPC	44
Proteomic-based analysis of testicular interstitial fluid	44

Microfluidic sperm selection	43
Prevalence of gender dysphoria in Japan	43
A new text message-based platform for self-management of patients with IC/BPS	40
What happens in Vegas … shapes the future of urology	39
Madrid plays host to a celebration of urology	39
Promise without practice — charting the path forward for bladder cancer biomarkers	39
Ibrexafungerp to treat acute vulvovaginal candidiasis	37
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	36
Galectins as potential therapeutic targets in STIs in the female genital tract	36
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	34
Metaverse in surgery — origins and future potential	34
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	34
Overcoming antibiotic resistance in complicated UTI	34
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	33
Evolution of the World Health Organization semen analysis manual: where are we?	32
Reducing the stigma of academic mental health can save lives	32
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	31
A non-invasive assay for UTUC diagnosis	31
Resolving the puzzle of same-sex sexual interactions	31
COVID can’t kill CopMich collaboration	31
Pembrolizumab + axitinib beyond first-line therapy for mRCC	31
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	29
The mechanism of action of neuromodulation in the treatment of overactive bladder	29
Efficacy of the Revi system in treating urgency urinary incontinence	29
Personalized 3D models for prostate cancer surgery	29
Vaccination to prevent untreatable gonorrhoea	29
PEACEing together prostate cancer therapy	29
Measuring and improving the cradle-to-grave environmental performance of urological procedures	28
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	28
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	28
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	27
Effect of high glucose on E. coli	26
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	25
Is it time to rethink the current patient-reported outcome measures?	25
Sexual orientation, gender identity and COVID: a complicated picture	24
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	23
Cribriform morphology affects mpMRI imaging	23
Secondary kidney stones — remove or leave?	23
The magic of MagSToNE	23
AUA returns to its former glory in Chicago	22
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	22
Successful mentorship for women in urology — a new era	22
Women in urology: the past	22
A clinical overview of people living with HIV and genitourinary cancer care	22
Microultrasonography-guided prostate cancer biopsy	21
Promising efficacy of UTI vaccines as an alternative to antibiotics	21
Prostate cancer in transgender women — challenges in research and clinical care	21
Videourodynamics — role, benefits and optimal practice	20
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	20
The placebo and nocebo effects in functional urology	19

Robots learning to imitate surgeons — challenges and possibilities	19
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	18
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	17
Androgen receptor pathway inhibitor combination in prostate cancer	16
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	16
Metabolic response to immunotherapy in prostate cancer	16
Management and cost of stent encrustation in pregnancy	15
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	15
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	15
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	14
The future of patient-derived xenografts in prostate cancer research	14
Pride, not prejudice	14
The evolving treatment landscape of metastatic urothelial cancer	13
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	13
Turning up the heat: CTLA4 blockade in urothelial cancer	12
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	12
The prognostic role of stroma in UTUC	11
The unclear role of PET–CT in localized radiorecurrent prostate cancer	11
Immune-based therapies in penile cancer	11
The value of women urologists — individual and institutional imperatives to address salary equity	11
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	10
Hallmark discoveries in the biology of Wilms tumour	10
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	10
Uncovering a link between COVID-19 and renal cell carcinoma	10
The shifting treatment paradigm of metastatic renal cell carcinoma	10
We all get erections — de-gendering sexual arousal dysfunction in the ICD	10
Turning back time in the testes	10
CMA mediates resistance to androgen inhibitors in prostate cancer	9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	9
Effects of COVID-19 vaccine on semen parameters	9
BAUSing back in Birmingham	9
Improved phenotypic classification of male infertility to promote discovery of genetic causes	9
Understanding iGCA	9
Pelvic-fascia-sparing techniques and outcomes with RARP	9
Current and future pharmacotherapy for female sexual dysfunction	9
Patient selection is key in IMbassador250	8
Tuft cells in prostate cancer	8
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	8
Men hold the balance of power	8
Metabolism, mitochondria and metastasis in kidney cancer	8
Male infertility and somatic health — insights into lipid damage as a mechanistic link	8
Mellow yellow: BilR reduces bilirubin to urobilinogen	8
Power up to investigate PrEP	8
Diagnosis of ccRCC	8
Microbiota manipulation to prevent oxalate kidney stone formation	8
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	8
Genetic ancestry and racial differences in prostate tumours	7
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	7
Spatiotemporal trends in human semen quality	7
Sperm activity affected by endometriosis	7
Mechanisms of the Supra-T paradox	7
MRI diagnosis and radical prostatectomy outcomes	7
Semen parameters across testicular cancer stages	7
Advances in sliding clip renorrhaphy for partial nephrectomy	6
Pronouns in English: a user’s guide	6
The ins and outs of penile erection	6
Toilet-based continuous health monitoring using urine	6
Chlorination by-products in drinking water — association with bladder cancer risk	6
Syphilis on the rise — a need for alternative therapies and vaccines	6
Stepping up to prevent bacterial vaginosis recurrence	6
The future of pelvic lymph node dissection for urological malignancies	5
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning	5
Urology on a changing planet: links between climate change and urological disease	5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	5
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	5
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	5
The effects of diet on prostate cancer outcomes	5
ADT intensification to treat biochemically recurrent prostate cancer	5
Genetic and biological drivers of prostate cancer disparities in Black men	5
Artificial intelligence in the management of prostate cancer	5
Testosterone replacement therapy and spermatogenesis in reproductive age men	5
Visual clues — dermatological manifestations of sexually transmitted infections in men	5
Pregnancy and parental leave in medicine and academia — a focus on urology	5
Feasibility and potential of an MRI-based prostate cancer screening	5
Prescribing clinician specialty influences adherence to PrEP	5
Clinical trial design for non-muscle-invasive bladder cancer	5
Prostate luminal progenitor cells: from mouse to human, from health to disease	5
Particulate matter leaves a bitter taste in testes	5
Influence of substance use on male reproductive health and offspring outcomes	5